Locations:
Search IconSearch
September 29, 2017/Urology & Nephrology/Urology

New Men’s Health Center Addresses Systemic Health and Urologic Conditions

One-stop shop elevates access to complete care

Shoskes

By Daniel Shoskes, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Central to the new Cleveland Clinic Center for Men’s Health is the recognition that systemic health conditions can have major impact on urologic conditions and their symptoms.

Benign prostatic hypertrophy (BPH); lower urinary tract symptoms (LUTS); erectile dysfunction (ED); adult-onset hypogonadism and pelvic pain, including chronic prostatitis/chronic pelvic pain syndrome (CPPS); and chronic orchialgia all can be affected by chronic disease. For instance, symptoms of LUTS, ED and CPPS are often exacerbated by cardiovascular disease and its treatment, and by low testosterone and diabetes. Furthermore, ED or LUTS could be the first manifestation of cardiovascular disease or poor diabetic control.

The Department of Urology at Cleveland Clinic created the Center for Men’s Health in August. Our goal is to improve the care of men with urologic conditions by bringing together urologists, cardiologists and endocrinologists. This allows patients to see multiple specialists at the same visit.

Other experts participating in the center treat exacerbating comorbidities. They include a psychologist/sex therapist, sleep medicine specialist (sleep apnea is associated with LUTS and ED) and pelvic floor physical therapists.

We have found that providing a “one-stop shop” speeds access and improves compliance.

New men’s health phenotype

Central to our approach is a new men’s health phenotype. This phenotype, with the acronym ACTIONS, classifies men according to presence and severity of seven conditions:

  • Anxiety/alarm falsification,
  • Cardiovascular disease,
  • Low testosterone,
  • Insulin deficiency/resistance (diabetes),
  • Obesity
  • Neurologic disease
  • Sleep apnea

Advertisement

Our team has shown a correlation between total burden of systemic disease and severity of urologic symptoms. We hypothesize that the greater the systemic comorbidity burden, the less likely specific urologic interventions (medical or surgical) are likely to succeed. This is the subject of prospective research submitted for publication.

Easy access is key

It is no secret that men could be better at tending to their health and seeking the medical care they need, and we continue to look for ways to improve access for our male patients. Expanding clinic hours into the evening and weekend is one approach. We are also sending staff to regional centers, including our Lakewood LGBT Clinic. We also are working with oncology colleagues to ensure rapid access to penile injection teaching for cancer patients with ED. We provide testosterone pellet implants (long-acting testosterone pellet inserted into hip or other fatty area) when endocrinologists do not perform the procedure.

New technique and technology

Finally, we are looking to new technology to enhance our therapeutic options for these men. Under the leadership of urologist James Ulchaker, MD, we have been early adopters of new BPH technologies, including UroLift® System and Rezūm® System. For several years, we have offered spermatic cord denervation for chronic orchialgia. More recently, we have added low-intensity shockwave therapy . This technique can painlessly improve penile blood flow in men with ED, leading to successful erections in over 60 percent of patients. It can also be used to improve pain in CPPS, especially in men with pelvic floor spasm.

Advertisement

Dr. Shoskes, Glickman Urological & Kidney Institute urologist, is Director of the Cleveland Clinic Center for Men’s Health.

Advertisement

Related Articles

Man sitting at kitchen table with blood pressure monitor and pill bottles

Should Patients Take Blood Pressure Medications in the Evening to Enhance Cardiovascular Benefit?

Clinicians should individualize dosing practices based on patient risk factors and preferences

Drawing of surgeon's fingers pressing into a patient's body

Low Anterior Access Enhances Outcomes in Single-Port Robotic Urologic Surgeries

Pioneering and refining the approach in pyeloplasty, nephrectomy and more

Drawing of a pink bulb with two tubes coming out of the top

Predicting Post-Op GFR: AI Algorithm Is as Accurate as Clinical Model

Fully-automated process uses preop CT, baseline GFR to estimate post-nephrectomy renal function

Arm of Black patient having kidney dialysis

GFR Equations: How Will Eliminating the Race Coefficient Affect Black Patients?

Could mean earlier treatment, but also could have negative effects

Man examining prescription bottle in kitchen
February 27, 2024/Urology & Nephrology/Urology

Oral Medication Offers New Option for Testosterone Replacement

Unlike earlier pills, new drugs do not cause liver toxicity

URL_Pavelko_3777858_Urology_Dr. Lundy in Clinic_04-26-23_LDJ
January 30, 2024/Urology & Nephrology/Urology

Starting the Conversation About Male Infertility

Male factors play a role in about half of all infertility cases, yet men often are not evaluated

URL_Mould_4456309_Dr. Jihad Kaouk during Procedure_12-12-23

Using One Single-Port Robot for Both Kidney Transplant Donor and Recipient

Surgeons choreograph nearly simultaneous procedures, sharing one robot between two patients

Senior at the Doctors

Study Assesses the Utility of Renal Genetic Testing in Black Patients

Identifying barriers in the renal genetic assessment of Black patients

Ad